Veeva Systems (VEEV) fundamentals: P/E, valuation, undervalued?
Veeva Systems · Health Care · ref. ETF XLV · price $282.13
In short — Veeva Systems trades at 46.3× earnings (P/E), 27.6× forward, with a net margin of 28.4 % and revenue growth of +16 %. Read: Fairly valued (P/E 28 in line with ~15% growth (PEG 1.9)).
Is Veeva Systems stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$282.13+3.6% over range
Aug 28, 25low $151.43 · high $306.22Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
65% recommend buying · 20 analysts
Valuation : Fairly valued — P/E 28 in line with ~15% growth (PEG 1.9)
Valuation
46.3
P/E (price/earnings)
27.6
Forward P/E
3.17
PEG
6.3
Price/book (P/B)
$45.8B
Market cap
6.10
EPS
Profitability & growth
28.4 %
Net margin
+16 %
Revenue growth
+15 %
Earnings growth
$103M
Total debt
Veeva Systems income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2023 | $2.2B | $488M | 22.6 % |
| 2024 | $2.4B | $526M | 22.2 % |
| 2025 | $2.7B | $714M | 26.0 % |
| 2026 | $3.2B | $909M | 28.4 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is Veeva Systems's P/E and is the stock undervalued? What's a good P/E?
Veeva Systems's P/E is 46.3 (forward 27.6). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Fairly valued".
Is Veeva Systems profitable?
Veeva Systems has a net margin of 28.4 % (EPS 6.10). The company is profitable.
Is VEEV stock expensive?
Our read: "Fairly valued" — P/E 28 in line with ~15% growth (PEG 1.9). Cross-check with growth and sector.
💬 A question about Veeva Systems? The JPI assistant answers using our backtest data.